Related Experiment Video
Updated: Jun 2, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
What are the costs of atrial fibrillation?
Carina Blomstrom Lundqvist1, Gregory Y H Lip, Paulus Kirchhof
1Department of Medical Science, Uppsala University, Sweden.
Insights
The cost of atrial fibrillation (AF) management is complex, influenced by patient care, complications like stroke, and indirect costs. Accurate cost assessment requires local data and caution with estimates.
Area of Science:
- Cardiology
- Health Economics
Background:
- Atrial fibrillation (AF) management incurs significant costs, encompassing direct patient care and indirect expenses like lost productivity.
- Estimating the economic burden of AF is challenging due to varying healthcare systems and cost determinants.
Purpose of the Study:
- To analyze the multifaceted costs associated with atrial fibrillation (AF) and its management.
- To highlight the need for cautious interpretation of AF cost estimates and emphasize local context.
Main Methods:
- Review of cost factors in AF patient management, including direct medical costs, hospitalizations, and long-term complications.
- Consideration of indirect costs such as workforce loss and non-medical expenses.
Main Results:
- AF costs are driven by patient management, complications (stroke, hospitalizations), and indirect factors.
- Cost estimations are assumption-dependent and vary significantly across healthcare settings.
- Newer therapies may increase upfront costs but promise to reduce long-term expenditures by preventing complications.
Conclusions:
- Accurate assessment of AF costs necessitates adjustment for local practices and further data, particularly from primary care.
- Relative cost-effectiveness of interventions can differ based on direct and indirect cost implications in various healthcare environments.
Abstract:
The costs of atrial fibrillation (AF) are linked to the general cost of managing AF patients in different health-care systems, as well as the cost of managing AF-related complications (e.g. hospitalizations and long-term complications, such as stroke). In addition, indirect medical costs, such as care for patients who do not recuperate fully from a vascular event, and non-medical costs such as loss of work force add to the costs of AF. All estimations for cost of AF and cost of AF therapy are based on assumptions and markedly influenced by these cost determinants. This urges for extreme caution not to take cost estimates at their absolute values. In fact, even relative comparisons between interventions may have different consequences in terms of direct and indirect costs in different health-care settings. While newer therapeutic options appear to increase the cost of AF management, newer antithrombotic substances and adequate rhythm control therapy also carry the promise of preventing the two major drivers of AF-related cost, hospitalizations and AF-related complications. Formal assessment of the cost of AF requires adjustment to local practice, and more data are clearly needed especially from primary care to better estimate the 'real' cost impact of AF.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias VI: Management of Dysrhythmias
Rheumatic Heart Disease I: Introduction
Dysrhythmias II: Classification of Tachyarrhythmias
Aortic Regurgitation III: Medical Management

